Literature DB >> 28548599

An extent of resection threshold for seizure freedom in patients with low-grade gliomas.

David S Xu1, Al-Wala Awad1, Chad Mehalechko2, Jeffrey R Wilson2, Lynn S Ashby3, Stephen W Coons4, Nader Sanai1.   

Abstract

OBJECTIVE Seizures are the most common presenting symptom of newly diagnosed WHO Grade II gliomas (low-grade glioma [LGG]) and significantly impair quality of life. Although gross-total resection of LGG is associated with better seizure control, it remains unclear whether an extent of resection (EOR) "threshold" exists for long-term seizure control. Specifically, what proportion of FLAIR-positive tissue in patients with newly diagnosed LGG must be removed to achieve Engel Class I seizure freedom? To clarify the EOR threshold for long-term seizure control, the authors analyzed data from a consecutive series of patients with newly diagnosed LGG who presented with seizures and subsequently underwent microsurgical resection. METHODS The authors identified consecutive patients with newly diagnosed LGG who presented with seizures and were treated at the Barrow Neurological Institute between 2002 and 2012. Patients were dichotomized into those who were seizure free postoperatively and those who were not. The EOR was calculated by quantitative comparison of pre- and postoperative MRI. Univariate analysis of these 2 groups included the chi-square test and the Mann-Whitney U-test, and a multivariate logistic regression was constructed to predict the impact of multiple independent variables on the likelihood of postoperative seizure freedom. To determine a threshold of EOR that optimizes seizure freedom, a receiver operating characteristic curve was plotted and the optimal point of discrimination was determined. RESULTS Data from 128 patients were analyzed (male/female ratio 1.37:1; mean age 40.8 years). All 128 patients presented with seizures, usually generalized (n = 57, 44.5%) or simple partial (n = 57, 44.5%). The median EOR was 90.0%. Of 128 patients, 46 (35.9%) had 100% volumetric tumor resection, 64 (50.0%) had 90%-99% volumetric tumor resection, and 11 (8.6%) had 80%-89% volumetric tumor resection. Postoperatively, 105 (82%) patients were seizure free (Engel Class I); 23 (18%) were not (Engel Classes II-IV). The proportion of seizure-free patients increased in proportion to the EOR. Predictive variables included in the regression model were preoperative Karnofsky Performance Scale score, seizure type, time from diagnosis to surgery, preoperative number of antiepileptic drugs, and EOR. Only EOR significantly affected the likelihood of postoperative Engel Class I status (OR 11.5, 95% CI 2.4-55.6; p = 0.002). The receiver operating characteristic curve generated based on Engel Class I status showed a sensitivity of 0.65 and 1 - specificity of 0.175, corresponding to an EOR of 80%. CONCLUSIONS For adult patients with LGG who suffer seizures, the results suggest that seizure freedom can be attained when EOR > 80% is achieved. Improvements in both the proportion of seizure-free patients and the durability of seizure freedom were observed beyond this 80% threshold. Interestingly, this putative EOR seizure-freedom threshold closely approximates that reported for the overall survival benefit in newly diagnosed hemispheric LGGs, suggesting that a minimum level of residual tumor burden is necessary for both disease and symptomatic progression.

Entities:  

Keywords:  AED = antiepileptic drug; EOR = extent of resection; Engel classification; KPS = Karnofsky Performance Scale; LLG = low-grade glioma; ROC = receiver operating characteristic; extent of resection; low-grade glioma; oncology; seizure

Mesh:

Substances:

Year:  2017        PMID: 28548599     DOI: 10.3171/2016.12.JNS161682

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  15 in total

1.  Early and maximal safe functional-based resection improves both survival and seizure control in adult diffuse low-grade glioma patients.

Authors:  Johan Pallud
Journal:  Neurooncol Pract       Date:  2020-06-24

Review 2.  What Have We Learned from Recent Clinical Studies in Low-Grade Gliomas?

Authors:  Roberta Rudà; Francesco Bruno; Riccardo Soffietti
Journal:  Curr Treat Options Neurol       Date:  2018-07-04       Impact factor: 3.598

3.  Seizures in patients with IDH-mutated lower grade gliomas.

Authors:  Louise Carstam; Isabelle Rydén; Asgeir Store Jakola
Journal:  J Neurooncol       Date:  2022-10-18       Impact factor: 4.506

4.  Video-Mosaicked Handheld Dual-Axis Confocal Microscopy of Gliomas: An ex vivo Feasibility Study in Humans.

Authors:  Yoko Fujita; Linpeng Wei; Patrick J Cimino; Jonathan T C Liu; Nader Sanai
Journal:  Front Oncol       Date:  2020-08-27       Impact factor: 6.244

Review 5.  Surgical oncology for gliomas: the state of the art.

Authors:  Nader Sanai; Mitchel S Berger
Journal:  Nat Rev Clin Oncol       Date:  2017-11-21       Impact factor: 66.675

Review 6.  Extent of resection in diffuse low-grade gliomas and the role of tumor molecular signature-a systematic review of the literature.

Authors:  Lucas Alverne F Albuquerque; João Paulo Almeida; Leonardo José Monteiro de Macêdo Filho; Andrei F Joaquim; Hugues Duffau
Journal:  Neurosurg Rev       Date:  2020-08-07       Impact factor: 3.042

7.  Predictors of early, recurrent, and intractable seizures in low-grade glioma.

Authors:  Jasmin Jo; Kathryn Nevel; Ryan Sutyla; Mark Smolkin; M Beatriz Lopes; David Schiff
Journal:  Neurooncol Pract       Date:  2020-08-29

8.  Seizure burden pre- and postresection of low-grade gliomas as a predictor of tumor progression in low-grade gliomas.

Authors:  Fernando Santos-Pinheiro; Mingjeong Park; Diane Liu; Lawrence N Kwong; Savannah Cruz; Nicholas B Levine; Barbara J O'Brien; Merry Chen
Journal:  Neurooncol Pract       Date:  2018-07-09

9.  New-Onset Postoperative Seizures in Patients With Diffuse Gliomas: A Risk Assessment Analysis.

Authors:  Lianwang Li; Guanzhang Li; Shengyu Fang; Kenan Zhang; Ruoyu Huang; Yinyan Wang; Chuanbao Zhang; Yiming Li; Wei Zhang; Zhong Zhang; Qiang Jin; Dabiao Zhou; Xing Fan; Tao Jiang
Journal:  Front Neurol       Date:  2021-06-18       Impact factor: 4.003

10.  Molecular Classification of Gliomas is Associated with Seizure Control: A Retrospective Analysis.

Authors:  Teresa P Easwaran; Nicola Lancki; Mario Henriquez; Alexander O Vortmeyer; Nicholas M Barbaro; Denise M Scholtens; Atique U Ahmed; Mahua Dey
Journal:  Neuromolecular Med       Date:  2020-11-18       Impact factor: 4.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.